HLB Therapeutics Co.,Ltd. announced a private placement of 1,150,000 common shares at an issue price of KRW 11,312 per share for gross proceeds of KRW 13,008,800,000 on January 4, 2023. The transaction included participation from returning investor, HLB Co., Ltd. The company will issue shares through third part allocation method. The transaction is expected to close on January 12, 2023.

The transaction has been approved by the board of directors of the company.